Paul Andrei Negru

400 total citations
25 papers, 283 citations indexed

About

Paul Andrei Negru is a scholar working on Infectious Diseases, Computational Theory and Mathematics and Molecular Biology. According to data from OpenAlex, Paul Andrei Negru has authored 25 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Computational Theory and Mathematics and 4 papers in Molecular Biology. Recurrent topics in Paul Andrei Negru's work include Computational Drug Discovery Methods (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and COVID-19 Clinical Research Studies (3 papers). Paul Andrei Negru is often cited by papers focused on Computational Drug Discovery Methods (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and COVID-19 Clinical Research Studies (3 papers). Paul Andrei Negru collaborates with scholars based in Romania, India and China. Paul Andrei Negru's co-authors include Simona Bungău, Andrei-Flavius Radu, Delia Mirela Ţiţ, Tapan Behl, Syed Shams ul Hassan, Florin Marcu, Felicia Liana Andronie-Cioară, Constantin Bungău, Alexa Florina Bungău and Bianca Pașca and has published in prestigious journals such as Annals of the New York Academy of Sciences, Molecules and Sustainability.

In The Last Decade

Paul Andrei Negru

20 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Andrei Negru Romania 9 53 35 31 27 22 25 283
Tong Tong China 9 116 2.2× 28 0.8× 37 1.2× 32 1.2× 24 1.1× 42 444
Yalin Liu China 13 104 2.0× 21 0.6× 21 0.7× 5 0.2× 27 1.2× 61 422
Gehan M. Elossaily Saudi Arabia 11 79 1.5× 27 0.8× 26 0.8× 14 0.5× 8 0.4× 39 334
Kanive Parashiva Guruprasad India 13 154 2.9× 20 0.6× 42 1.4× 12 0.4× 19 0.9× 38 420
Lushan Wang China 10 83 1.6× 27 0.8× 28 0.9× 4 0.1× 14 0.6× 31 298
Qingqing Shen China 8 101 1.9× 31 0.9× 35 1.1× 7 0.3× 6 0.3× 12 341
Yu‐Chieh Lin Taiwan 10 126 2.4× 44 1.3× 28 0.9× 20 0.7× 8 0.4× 32 345
Prasanta Kumar Sarkar India 11 43 0.8× 24 0.7× 7 0.2× 12 0.4× 23 1.0× 35 376
Atif Akbar Pakistan 13 53 1.0× 10 0.3× 29 0.9× 2 0.1× 30 1.4× 64 435
Dhruv Gupta India 11 126 2.4× 28 0.8× 51 1.6× 4 0.1× 10 0.5× 29 403

Countries citing papers authored by Paul Andrei Negru

Since Specialization
Citations

This map shows the geographic impact of Paul Andrei Negru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Andrei Negru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Andrei Negru more than expected).

Fields of papers citing papers by Paul Andrei Negru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Andrei Negru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Andrei Negru. The network helps show where Paul Andrei Negru may publish in the future.

Co-authorship network of co-authors of Paul Andrei Negru

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Andrei Negru. A scholar is included among the top collaborators of Paul Andrei Negru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Andrei Negru. Paul Andrei Negru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Negru, Paul Andrei, Delia Mirela Ţiţ, & Simona Bungău. (2025). SUSPECTED ADVERSE DRUG REACTIONSTO FAVIPIRAVIR: INSIGHTS FROM EUDRAVIGILANCEREPORTS. Archives of the Balkan Medical Union. 60(1). 69–76. 1 indexed citations
3.
Ţiţ, Delia Mirela, et al.. (2025). Bibliometric Analysis of Medical Waste Research Using Python-Driven Algorithm. Algorithms. 18(6). 312–312. 1 indexed citations
4.
Radu, Andrei-Flavius, et al.. (2025). Unraveling the Scientific Landscape of Osteoarthritis: Dynamics of Publications over Five Decades. Bioengineering. 12(6). 602–602.
5.
Bungău, Simona, et al.. (2024). Evaluation of the Alkaloids as Inhibitors of Human Acetylcholinesterase by Molecular Docking and ADME Prediction. In Vivo. 39(1). 236–250. 1 indexed citations
6.
Negru, Paul Andrei, et al.. (2024). Integrated Insights into Metabolic and Bariatric Surgery: Improving Life Quality and Reducing Mortality in Obesity. Medicina. 61(1). 14–14. 2 indexed citations
7.
Bungău, Constantin, et al.. (2023). Implementing Circular Economy Elements in the Textile Industry: A Bibliometric Analysis. Sustainability. 15(20). 15130–15130. 12 indexed citations
8.
Bungău, Simona, Paul Andrei Negru, Andrei-Flavius Radu, et al.. (2023). Exploring New Therapeutic Avenues for Ophthalmic Disorders: Glaucoma-Related Molecular Docking Evaluation and Bibliometric Analysis for Improved Management of Ocular Diseases. Bioengineering. 10(8). 983–983. 10 indexed citations
9.
Bungău, Simona, et al.. (2023). Immune recovery among Romanian HIV/AIDS patients receiving darunavir/ritonavir or darunavir/cobicistat regimens in cART management: A three-year study. Biomedicine & Pharmacotherapy. 161. 114427–114427. 1 indexed citations
10.
Radu, Andrei-Flavius, et al.. (2023). Novel Potential Janus Kinase Inhibitors with Therapeutic Prospects in Rheumatoid Arthritis Addressed by In Silico Studies. Molecules. 28(12). 4699–4699. 10 indexed citations
12.
Negruţ, Nicoleta, et al.. (2023). Inequities in Antiviral Therapy for Diabetic Individuals Affected by COVID-19. 3(1). 9–20. 2 indexed citations
14.
Negru, Paul Andrei, Andrei-Flavius Radu, Cosmin Mihai Vesa, et al.. (2022). Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir. Biomedicine & Pharmacotherapy. 147. 112700–112700. 22 indexed citations
15.
Radu, Andrei-Flavius, Simona Bungău, Paul Andrei Negru, Florin Marcu, & Felicia Liana Andronie-Cioară. (2022). In-depth bibliometric analysis and current scientific mapping research in the context of rheumatoid arthritis pharmacotherapy. Biomedicine & Pharmacotherapy. 154. 113614–113614. 60 indexed citations
16.
Uivaroșan, Diana, Simona Bungău, Carmen Delia Nistor-Cseppento, et al.. (2022). Application of Robotic Recovery Techniques to Stroke Survivors—Bibliometric Analysis. Journal of Personalized Medicine. 12(12). 2066–2066. 8 indexed citations
17.
Nechifor, M, et al.. (1995). Influence of Clonidine on Alloxan‐Induced Diabetes in Rats. Annals of the New York Academy of Sciences. 763(1). 377–379. 1 indexed citations
18.
Nechifor, M, et al.. (1995). The influence of some cations on PAF-induced gastric mucosal damage in rats.. PubMed. 30(3-4). 151–4. 1 indexed citations
19.
Nechifor, M, et al.. (1992). [Pharmacological studies of sulbactam and its association with semisynthetic beta-lactam antibiotics].. PubMed. 96(1-2). 51–5. 3 indexed citations
20.
Nechifor, M, et al.. (1992). Influence of cloprostenol in the experimentally induced ulcer in rats.. PubMed. 96 Suppl. 10–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026